Heramed Limited (ASX:HMD)


right-arrow Created with Sketch. 0.005 (1.82%)
MCAP $49.61M
Last trade 16.10pm 01/12/2021 20mins delayed

Latest Announcements

18/11/2021HMDHeramed Limited
15/11/2021HMDHeramed Limited
15/11/2021 Price SensitivePSHMDHeramed Limited
29/10/2021HMDHeramed Limited
29/10/2021 Price SensitivePSHMDHeramed Limited
28/10/2021HMDHeramed Limited
18/10/2021HMDHeramed Limited
18/10/2021 Price SensitivePSHMDHeramed Limited

Company Overview

Hera Med Ltd is an Israel-based company that develops pregnancy monitoring solutions for home and professional use. It offers hardware solutions supported by software applications. Its product HeraBEAT, is a medical-grade, clinically-validated and connected Ultrasound Fetal Doppler device predominantly for use by an expectant mother to self-monitor her fetus’ heart rate (FHR) at home. HeraBEAT communicates with any smartphone (iOS/Android) through Bluetooth Low Energy (BLE). A mother can hold or strap the HeraBEAT device to her abdomen, and the collected data is transmitted to her smartphone where the relevant readings are displayed through an interface. The Company also develops a service model which includes a homecare pregnancy solution. In addition, the Company develops artificial intelligence (AI), machine-learning, computerized algorithms to monitor and analyze the data so a healthcare professional or home user is informed of the wellbeing of the fetus.

HMD in the news

Medical tech company HeraMED (HMD) raises roughly $2.39 million through a convertible…
Pregnancy technology company HeraMED (HMD) receives interim results from its paid pilot…
Maternity care company HeraMED’s (HMD) digital monitoring technology, HeraCare, has been shortlisted…

Search Previous Announcements